Divi’s Laboratories Limited announced its Q1FY21 results on Aug 8, 2020. Consolidated net revenue of Divi’s Laboratories Limited in Q1FY21 stood at Rs1,730.47cr, which rose by 48.81% yoy from Rs1,162.88cr in Q1FY20.
EBITDA stood at Rs700.08cr in Q1FY21 which rose by 80.83% yoy. For Q1FY20, it had posted EBITDA of Rs387.14cr. EBITDA margin as of Q1FY21 was at 40.46% which rose by 7.17% yoy against the same quarter, the previous year.
The consolidated net profit in Q1FY21 came in at Rs492.06cr which rose by 80.61%, as compared to Q1FY20, when it had reported Rs272.44cr. The net profit margin in Q1FY21 came in at 28.44% which rose by 5.01% yoy. The net profit margin for Q1FY20 was 23.43%.
On Friday, the share closed at Rs2,784.25 up by 1.25% on BSE.
|
Particulars |
Q1FY21 (Rs in cr) |
Q1FY20 (Rs in cr) |
% VAR |
|
Net Revenue |
1,730.47 |
1,162.88 |
48.81 |
|
Operating Profit |
700.08 |
387.14 |
80.83 |
|
Net Profit |
492.06 |
272.44 |
80.61 |
|
EBITDAM% |
40.46 |
33.29 |
7.17 |
|
PATM% |
28.44 |
23.43 |
5.01 |
Related Tags:
